Efficacy and Safety of AR101 in Oral Immunotherapy for Peanut Allergy: Results of ARC001, a Randomized, Double-Blind, Placebo-Controlled Phase 2 Clinical Trial

J. Andrew Bird, Jonathan M. Spergel, Stacie M. Jones, Rima Rachid, Amal H. Assa'ad, Julie Wang, Stephanie A. Leonard, Susan S. Laubach, Edwin H. Kim, Brian P. Vickery, Benjamin P. Davis, Jennifer Heimall, Antonella Cianferoni, Andrew J. MacGinnitie, Elena Crestani, A. Wesley Burks